Basics |
Company: |
Pulmonx Corporation |
IPO Date: |
October 1, 2020 |
Sector: |
Healthcare |
Industry: |
Medical Devices |
Market Cap: |
$353.81M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.61 | 2.88%
|
Avg Daily Range (30 D): |
$0.23 | 3.53%
|
Avg Daily Range (90 D): |
$0.21 | 3.17%
|
Institutional Daily Volume |
Avg Daily Volume: |
.31M |
Avg Daily Volume (30 D): |
.31M |
Avg Daily Volume (90 D): |
.23M |
Trade Size |
Avg Trade Size (Sh.): |
73 |
Avg Trade Size (Sh.) (30 D): |
85 |
Avg Trade Size (Sh.) (90 D): |
79 |
Institutional Trades |
Total Inst.Trades: |
989 |
Avg Inst. Trade: |
$1.68M |
Avg Inst. Trade (30 D): |
$.76M |
Avg Inst. Trade (90 D): |
$.7M |
Avg Inst. Trade Volume: |
.08M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.63M |
Avg Closing Trade (30 D): |
$.51M |
Avg Closing Trade (90 D): |
$.54M |
Avg Closing Volume: |
66.1K |
|
|
|
|
Financials |
|
TTM |
Q1 2024 |
Q4 2023 |
Basic EPS
|
$-.39
|
$-.36
|
$-.36
|
Diluted EPS
|
$-.39
|
$-.36
|
$-.36
|
Revenue
|
$ 20.78M
|
$ 18.85M
|
$ 19.28M
|
Gross Profit
|
$ 15.31M
|
$ 14.08M
|
$ 14.4M
|
Net Income / Loss
|
$ -15.33M
|
$ -13.75M
|
$ -13.89M
|
Operating Income / Loss
|
$ -15.62M
|
$ -14.54M
|
$ -13.92M
|
Cost of Revenue
|
$ 5.48M
|
$ 4.78M
|
$ 4.88M
|
Net Cash Flow
|
$ -6.67M
|
$ -13.39M
|
$ -11.4M
|
PE Ratio
|
|
|
|
|